A randomized, double‐blind, placebo‐controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, in patients with corticosteroid‐dependent Crohn's disease
暂无分享,去创建一个
S. Hanauer | C. Bernstein | C. Elson | W. Sandborn | B. Feagan | F. Cominelli | G. Lichtenstein | L. Sutherland | B. Salzberg | J. Baker | L. Sutherland | A. Archambault | S. Hanauer | P. Heath | S. Cameron | J. Baker